Michael Metzger

Michael A. Metzger is currently Chief Executive Officer & Director at Syndax Pharmaceuticals, Inc. since 2022, Director at Northern Westchester Hospital Association, and Independent Director at Pyxis Oncology, Inc. since 2024.
Former roles include President, Chief Executive Officer & Director at Regado Biosciences, Inc. from 2014 to 2015; Independent Director at CTI BioPharma Corp.
from 2017 to 2023; Independent Director at Response Genetics, Inc. from 2010 to 2013; Managing Director at Mesa Partners, Inc. from 1997 to 2001; Director at Tarveda Therapeutics, Inc.; Head-Mergers & Acquisitions at Forest Laboratories, Inc. in 2011; Vice President-Corporate Development at Traws Pharma, Inc. from 2001 to 2006; Chief Operating Officer & Executive Vice President at Mersana Therapeutics, Inc. from 2011 to 2013; and President, Chief Executive & Operating Officer at Tobira Therapeutics, Inc. Education includes undergraduate studies at George Washington University and an MBA from The Leonard N Stern School of Business.